Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab

Research and Practice in Thrombosis and Haemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles